BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16476052)

  • 1. Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.
    Pouniotis DS; Apostolopoulos V; Pietersz GA
    Immunology; 2006 Mar; 117(3):329-39. PubMed ID: 16476052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
    André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
    J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
    Pouniotis DS; Esparon S; Apostolopoulos V; Pietersz GA
    Immunol Cell Biol; 2011 Nov; 89(8):904-13. PubMed ID: 21383765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity.
    Shibagaki N; Udey MC
    J Immunol; 2002 Mar; 168(5):2393-401. PubMed ID: 11859130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway.
    Kurotaki T; Tamura Y; Ueda G; Oura J; Kutomi G; Hirohashi Y; Sahara H; Torigoe T; Hiratsuka H; Sunakawa H; Hirata K; Sato N
    J Immunol; 2007 Aug; 179(3):1803-13. PubMed ID: 17641047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.
    Pouniotis D; Tang CK; Apostolopoulos V; Pietersz G
    Immunol Res; 2016 Aug; 64(4):887-900. PubMed ID: 27138940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A membrane penetrating multiple antigen peptide (MAP) incorporating ovalbumin CD8 epitope induces potent immune responses in mice.
    Brooks NA; Pouniotis DS; Sheng KC; Apostolopoulos V; Pietersz GA
    Biochim Biophys Acta; 2010 Dec; 1798(12):2286-95. PubMed ID: 20478265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides.
    Brooks N; Esparon S; Pouniotis D; Pietersz GA
    Molecules; 2015 Aug; 20(8):14033-50. PubMed ID: 26247926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines.
    Brossart P; Bevan MJ
    Blood; 1997 Aug; 90(4):1594-9. PubMed ID: 9269778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.
    van Mierlo GJ; Boonman ZF; Dumortier HM; den Boer AT; Fransen MF; Nouta J; van der Voort EI; Offringa R; Toes RE; Melief CJ
    J Immunol; 2004 Dec; 173(11):6753-9. PubMed ID: 15557168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells.
    Tanaka Y; Koido S; Ohana M; Liu C; Gong J
    J Immunol; 2005 Feb; 174(3):1274-80. PubMed ID: 15661883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses.
    Apostolopoulos V; Pouniotis DS; van Maanen PJ; Andriessen RW; Lodding J; Xing PX; McKenzie IF; Loveland BE; Pietersz GA
    Vaccine; 2006 Apr; 24(16):3191-202. PubMed ID: 16480791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery.
    Robson NC; McAlpine T; Knights AJ; Schnurr M; Shin A; Chen W; Maraskovsky E; Cebon J
    Blood; 2010 Jul; 116(2):218-25. PubMed ID: 20430956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells.
    Chikh GG; Kong S; Bally MB; Meunier JC; Schutze-Redelmeier MP
    J Immunol; 2001 Dec; 167(11):6462-70. PubMed ID: 11714813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway.
    Win SJ; Ward VK; Dunbar PR; Young SL; Baird MA
    Immunol Cell Biol; 2011 Aug; 89(6):681-8. PubMed ID: 21221122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway.
    Pietersz GA; Li W; Apostolopoulos V
    Vaccine; 2001 Jan; 19(11-12):1397-405. PubMed ID: 11163662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses.
    Vabulas RM; Pircher H; Lipford GB; Häcker H; Wagner H
    J Immunol; 2000 Mar; 164(5):2372-8. PubMed ID: 10679072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
    Kikuchi T; Uehara S; Ariga H; Tokunaga T; Kariyone A; Tamura T; Takatsu K
    Immunology; 2006 Jan; 117(1):47-58. PubMed ID: 16423040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct loading of CTL epitopes onto MHC class I complexes on dendritic cell surface in vivo.
    Wang P; Dong S; Zhao P; He X; Chen M
    Biomaterials; 2018 Nov; 182():92-103. PubMed ID: 30107273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.